| SAC | saccharin; sacrum; screening and acute care; Self-Assessment of Communication [scale]; short-arm cas... |
|---|---|
| SAD | Scale of Anxiety and Depression; seasonal affective disorder; Self-Assessment Depression [scale]; se... |
| SRS | schizophrenic residual state; sex reassignment surgery; Silver-Russell syndrome; simple repeat seque... |
| AAMD-ABS | American Association on Mental Deficiency-Adaptive Behavior Scale; ¹Ì±¹ Á¤½Å ¹Ú¾à Çùȸ ÀûÀÀ Çൿ ôµµ... |
| ABS | Adaptive Behavior Scale |
| outcome and process assessment | Evaluation procedures that focus on both the outcome or status (outcome assessment) of the patient at the end of an episode of care - presence of symptoms, level of activity, and mortality; and the process (process assessment) - what is done for the patient diagnostically and therapeutically. (12 Dec 1998) |
|---|---|
| outcome assessment | Research aimed at assessing the quality and effectiveness of health care as measured by the attainment of a specified end result or outcome. Measures include parameters such as improved health, lowered morbidity or mortality, and improvement of abnormal states (such as elevated blood pressure). (12 Dec 1998) |
| technology assessment, biomedical | Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems. (12 Dec 1998) |
| environmental assessment | (EA) A public document that analyzes a proposed federal action for the possibility of significant environmental impacts. The analysis is required by NEPA. If the environmental impacts will be significant, the federal agency must then prepare an environmental impact statement. (05 Dec 1998) |
| united states office of technology assessment | An office established to help congress participate and plan for the consequences of uses of technology. It provides information on both the beneficial and adverse effects of technological applications. (12 Dec 1998) |
| ABO haemolytic disease of the newborn | Erythroblastosis foetalis due to maternal-foetal incompatibility with respect to an antigen of the ABO blood group; the foetus possesses A or B antigen which is lacking in the mother, and the mother produces immune antibody which causes haemolysis of foetal erythrocytes. (05 Mar 2000) |
| bullous impetigo of newborn | Usually, widely disseminated bullous lesions appearing soon after birth, caused by infection with Staphylococcus aureus. Synonym: impetigo neonatorum, pemphigus gangrenosus. (05 Mar 2000) |
| respiratory distress syndrome of the newborn | A disease seen especially in premature neonates with respiratory distress; characterised postmortem by atelectasis and alveolar ducts lined by an eosinophilic membrane; also associated with reduced amounts of lung surfactant. Synonym: hyaline membrane syndrome, respiratory distress syndrome of the newborn. (05 Mar 2000) |
| pleural effusion in newborn | <radiology> Chylothorax most common cause of large effusion, erythroblastosis foetalis, Turner syndrome, congestive heart failure, infantile polycystic kidneys, wet-lung disease, hypervolaemia (idiopathic or iatrogenic), oesophageal tear, enteric cyst, obstructed pulmonary veins (12 Dec 1998) |
| congenital epulis of newborn | A congenital benign nodular tumour of the alveolar ridge, of unknown histogenesis; histologically, it is composed of large cells with a granular cytoplasm similar to that of a granular cell tumour (myoblastoma). (05 Mar 2000) |
| postnatal pit of the newborn | It marks the site where the embryonic spinal cord attaches to the skin. Synonym: postnatal pit of the newborn. (05 Mar 2000) |
| haemolytic anaemia of newborn | <haematology> A condition which develops in the foetus due to an incompatibility between the mother's blood type (RH factor) and the baby's. Maternal antibodies, which enter the foetal circulation during delivery attack the baby's red blood cells leading to haemolysis (rupture of the cells). Symptoms include an infant with an enlarged liver and spleen, swelling, jaundice and anaemia. (27 Sep 1997) |
| haemolytic disease of newborn | <haematology> A condition which develops in the foetus due to an incompatibility between the mother's blood type (RH factor) and the baby's. Maternal antibodies, which enter the foetal circulation during delivery attack the baby's red blood cells leading to haemolysis (rupture of the cells). Symptoms include an infant with an enlarged liver and spleen, swelling, jaundice and anaemia. (27 Sep 1997) |
| haemolytic disease of the newborn | Abnormal breakup of red blood cells in the foetus or newborn. This is usually due to antibodies made by the mother directed against the baby's red cells. It is typically caused by rh incompatibility, that is differences between the mother and baby uinvolving the rh blood group. (12 Dec 1998) |
| haemorrhagic disease of newborn | A self-limited haemorrhagic disorder of the first days of life, caused by a deficiency of the vitamin k-dependent blood coagulation factors II, vii, ix, and x. (12 Dec 1998) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|